Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 43204 in Actinic Keratosis
NCT01922050Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ingenol disoxate in actinic keratosis (AK), sponsored by LEO Pharma. Started Oct 2013; status: completed.
02
Drugs
ingenol disoxate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01922050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922050.